Abstract:Our findings provide an efficient combination strategy for increasing clinically important daptomycin production by enhancing aspartate precursor supply, abolishing by‐product red pigment production, engineering daptomycin biosynthetic gene cluster (BGC) by promoter replacement, and duplicating the engineered daptomycin BGC in Streptomyces roseosporus wild‐type strain. We finally obtained a maximal DAP titre of 350.7 μg/mL, representing the highest reported titre in shake‐flask fermentation. Such strategies can be readily applied in the overproduction of other antibiotics using aspartate as a precursor. Daptomycin (DAP), a novel cyclic lipopeptide antibiotic produced by Streptomyces roseosporus, is clinically important for treatment of infections caused by multidrug‐resistant Gram‐positive pathogens, but the low yield hampers its large‐scale industrial production. Here, we describe a combination metabolic engineering strategy for constructing a DAP high‐yielding strain. Initially, we enhanced aspartate (Asp) precursor supply in S. roseosporus wild‐type (WT) strain by separately inhibiting Asp degradation and competitive pathway genes using CRISPRi and overexpressing Asp synthetic pathway genes using strong promoter kasOp*. The resulting strains all showed increased DAP titre. Combined inhibition of acsA4, pta, pyrB, and pyrC increased DAP titre to 167.4 μg/mL (73.5% higher than WT value). Co‐overexpression of aspC, gdhA, ppc, and ecaA led to DAP titre 168 μg/mL (75.7% higher than WT value). Concurrently, we constructed a chassis strain favourable for DAP production by abolishing by‐product production (i.e., deleting a 21.1 kb region of the red pigment biosynthetic gene cluster (BGC)) and engineering the DAP BGC (i.e., replacing its native dptEp with kasOp*). Titre for the resulting chassis strain reached 185.8 μg/mL. Application of our Asp precursor supply strategies to the chassis strain further increased DAP titre to 302 μg/mL (2.1‐fold higher than WT value). Subsequently, we cloned the engineered DAP BGC and duplicated it in the chassis strain, leading to DAP titre 274.6 μg/mL. The above strategies, in combination, resulted in maximal DAP titre 350.7 μg/mL (2.6‐fold higher than WT value), representing the highest reported DAP titre in shake‐flask fermentation. These findings provide an efficient combination strategy for increasing DAP production and can also be readily applied in the overproduction of other Asp‐related antibiotics.

Optimization Study on Fermentative Medium for Precursor of Daptomycin A21978C Produced by Streptomyces roseosporus NRRL 11379

Optimization of fermentation conditions for production of a novel antifungal metabolite by response surface methodology

Fermentation process and kinetics of novel antifungal antibiotic production

Optimization of bacteriocin production by a new Lactobacillus strain, ZJ317, using response surface methodology

Optimization of Fermentation for Production Conditions of Antibiotic by Bacillus amyloliquefaciens D1

Improving the Yield and Quality of Daptomycin in Streptomyces Roseosporus by Multilevel Metabolic Engineering

Response Surface Methodology to Optimize Fermentation Technology of Brevibacillus brevis ch2-22

Optimization of Fermentation Medium for Production of Antibacterial Peptides by Bacillus Subtilis BSD-2

Metabolic Flux Analysis and Principal Nodes Identification for Daptomycin Production Improvement by Streptomyces Roseosporus

Enhancement of Daptomycin Production in Streptomyces Roseosporus LC-51 by Manipulation of Cofactors Concentration in the Fermentation Culture

Kinetic Analysis and Modeling of Daptomycin Batch Fermentation by Streptomyces Roseosporus

Strain Improvement of Streptomyces Roseosporus for Daptomycin Production by Rational Screening of He–Ne Laser and NTG Induced Mutants and Kinetic Modeling

Optimization of Fermentation Conditions for Trichodermin by the Mutant Strain UL60-11 of Trichoderma Taxi.

Optimization of Medium Constituents for Ε-Poly-l-lysine Fermentation with Response Surface Methodology.

Medium Optimization Based on Statistical Methodologies for Pristinamycins Production by Streptomyces Pristinaespiralis

Metabolic engineering of Streptomyces roseosporus for increased production of clinically important antibiotic daptomycin

In silico aided metabolic engineering of Streptomyces roseosporus for daptomycin yield improvement

Optimization of the Biosynthetic Conditions on FDP Production by Yeast Strain F15

Daptomycin production enhancement by ARTP mutagenesis and fermentation optimization in Streptomyces roseosporus

Optimization of Culture Conditions for Production of Cis-Epoxysuccinic Acid Hydrolase Using Response Surface Methodology

Fermentation Process Optimization of Novel Immunosuppressant Sanglifehrin A